Sourcing Accurate AI Scribes: A Clinical Validation Framework

• Transcription Is Easy; Clinical Reasoning Is Hard — The Gap Every AI Scribe Evaluation Misses

• Scribing.io Clinical Logic: Handling Modifier 25 Separation in Dermatology — Before and After

• The Correction Log: Step-by-Step Clinical Reasoning Breakdown

• Technical Reference: ICD-10 Documentation Standards for Dermatologic Procedures

• Why the AMA's Five Domains Are Necessary but Insufficient for AI Scribe Evaluation

• The Six-Domain Clinical Validation Framework for AI Scribe Procurement

• Head-to-Head Vendor Testing: How to Run a Reasoning Audit

• Conversion: The 15-Minute Workflow Audit

TL;DR

The AMA's AI Evaluation Guide provides a foundational five-domain framework for assessing clinical AI—but it stops at general principles and never addresses the revenue-cycle failures that Medical Directors actually confront: modifier 25 denials, blended E/M-plus-procedure documentation, and the absence of auditable correction provenance. This playbook closes that gap. It introduces a clinical validation framework built on the insight that transcription is easy; clinical reasoning is hard, demonstrates how Scribing.io's specialty-tuned Correction Log outperformed generic LLMs in 92% of head-to-head cases, and provides the ICD-10-to-CPT linking methodology that turns documentation from a liability into audit-ready evidence. If you evaluate AI scribes without testing their reasoning logic against payer scrutiny, you are optimizing the wrong metric.

Transcription Is Easy; Clinical Reasoning Is Hard — The Gap Every AI Scribe Evaluation Misses

The prevailing industry benchmark for AI scribe quality is word error rate (WER). Vendors compete to shave fractions of a percent off transcription accuracy as though dictation fidelity is the bottleneck. It is not. A note can be transcribed with 99% word-level accuracy and still produce a claim denial because the clinical reasoning behind code selection, modifier attachment, and medical-decision-making (MDM) stratification was never validated. WER measures whether the microphone heard "actinic keratosis." It does not measure whether the system understood that actinic keratosis is premalignant, maps to CPT 17000 and not 17110, and requires narrative separation from the same-visit E/M when modifier 25 is applied.

The AMA AI Specialty Collaborative's 2026 Evaluation Guide—an important contribution—frames AI assessment across five domains: clinical use case, training data, risk mitigation, effectiveness, and workflow integration. These domains are structurally sound. But the guide addresses AI in medicine generically. It does not descend into the specific failure mode that costs multi-provider groups tens of thousands of dollars per quarter: payer scrutiny of CPT modifier 25. Scribing.io exists precisely in this gap—where clinical documentation quality and revenue-cycle integrity converge.

Here is the core problem. When a patient presents for both an evaluation-and-management (E/M) service and a minor procedure during the same encounter, the resulting documentation must satisfy two independently justified clinical narratives. A modifier 25 appended to the E/M code signals to the payer that the E/M was a "significant, separately identifiable" service, as defined under CMS NCCI guidelines. If the AI scribe blends these narratives—embedding the procedure rationale inside the E/M assessment, or failing to articulate distinct MDM for each—the claim is vulnerable. Payers increasingly deploy their own algorithms to detect blended documentation, and they deny or down-code accordingly. A JAMA Dermatology analysis confirmed that modifier 25 usage in dermatology carries among the highest audit-trigger rates across all specialties.

Competitors optimize for what the microphone hears. Scribing.io optimizes for what the payer audits.

Scribing.io's specialty-tuned models generate a versioned Correction Log that cleanly separates E/M medical decision-making from same-day minor procedures, links ICD-10 codes to CPT/HCPCS with modifier 25 (and modifiers 59/XE when applicable), and validates justification before provider signature. In head-to-head testing, this reasoning-first architecture outperformed generic large language models in 92% of cases—not on transcription fluency, but on the clinical-reasoning dimensions that determine whether a claim survives payer adjudication.

The same reasoning-first architecture that handles dermatologic modifier 25 logic extends across specialties. Our Cardiology accuracy benchmarks demonstrate how specialty tuning catches E/M stratification errors in complex cardiac encounters—where procedures like ECG interpretation (CPT 93010) performed during an established-patient visit trigger identical modifier 25 separation requirements. Meanwhile, our Psychiatry documentation module addresses the unique MDM challenges of behavioral-health coding where time-based E/M documentation introduces a separate class of reasoning failures that generic scribes handle poorly.

This is the foundational insight that should reshape how Medical Directors evaluate AI scribes: the validation framework must test reasoning output, not dictation input.

Scribing.io Clinical Logic: Handling Modifier 25 Separation in Dermatology — Before and After

This section is the operational centerpiece of the framework. It translates abstract validation principles into a concrete, auditable workflow using a real-world scenario that Medical Directors in dermatology and primary care encounter daily.

The Scenario

A 4-provider dermatology group performs cryotherapy (CPT 17000—destruction of premalignant lesions, first lesion) during problem-focused visits coded at 99213 or 99214. The same-day E/M requires modifier 25 to signal a separately identifiable service. The practice uses an ambient AI scribe to generate encounter documentation.

Before Scribing.io

Generic AI scribe platforms transcribe the encounter accurately at the word level but fail at the reasoning level:

• The procedure narrative (cryotherapy application, lesion description, informed consent) is blended into the E/M note body rather than documented as a distinct clinical event.

• Medical decision-making for the E/M is not independently articulated—there is no standalone assessment that justifies why the office visit itself met the threshold for 99213 or 99214 apart from the procedure.

• Medical necessity linking between diagnosis and procedure is implied but not explicitly documented in a payer-auditable format.

• No versioned audit trail exists showing what the AI suggested versus what the provider reviewed.

Measured impact over 30 days:

• 31% of 99213/99214 + 17000 claims lost E/M payment through modifier 25 down-coding or outright denial.

• ~$9,600 in lost revenue across the group.

• 5+ hours/week of provider and staff time consumed by addenda, resubmissions, and appeals.

After Scribing.io

Measured impact over 30 days:

• Denials dropped to 3%.

• $8,700 recovered in previously lost revenue.

• Provider after-hours charting time reduced by 4.2 hours/week.

• Staff time on addenda and appeals fell from 5+ hours to under 1 hour per week.

The next section breaks down exactly how the Correction Log produces these outcomes at each step of the encounter documentation lifecycle.

The Correction Log: Step-by-Step Clinical Reasoning Breakdown

This is the granular logic that separates a reasoning-first AI scribe from a transcription tool. Each step maps to a specific failure mode that generic LLMs miss.

Step 1: Encounter-Type Detection and Dual-Narrative Flagging

As the ambient audio stream is processed, Scribing.io's specialty-tuned model identifies encounter components in real time. When both E/M language (history of present illness, review of systems, assessment and plan with differential reasoning) and procedural language (lesion identification, preparation, instrument application, post-procedure instructions) co-occur, the system flags the encounter as a dual-narrative event. This flag triggers the modifier 25 separation protocol.

What generic LLMs miss: General-purpose models lack the training to distinguish between "the provider discussed the lesion" as E/M history versus "the provider treated the lesion" as procedure documentation. Both appear in the same audio stream. Without specialty-tuned segmentation, they produce a single narrative.

Step 2: MDM Stratification — Independent E/M Justification

The Correction Log isolates the E/M medical decision-making elements and evaluates them against CMS 2026 E/M guidelines for the claimed level. For a 99214, this means verifying:

1. Number and complexity of problems addressed: At least one chronic illness with mild exacerbation, or two or more stable chronic conditions, distinct from the procedural diagnosis.

2. Amount and/or complexity of data reviewed: Independent data review (prior biopsy results, medication history, imaging) documented as part of the E/M, not the procedure.

3. Risk of complications and/or morbidity: Prescription drug management or decision-making that carries moderate risk, documented separately from procedural risk discussion.

If the E/M MDM elements fall below the claimed level—a common occurrence when the only documented "complexity" is the lesion being treated—the Correction Log flags the discrepancy and presents it to the provider pre-signature with a specific recommendation: either supplement the E/M documentation or down-code to 99213.

What generic LLMs miss: They auto-assign the E/M level based on total encounter complexity, including the procedure, rather than isolating the E/M-specific decision-making. This inflates the E/M level and creates the exact audit vulnerability payers target.

Step 3: Procedure Narrative Isolation

Simultaneously, the Correction Log extracts the procedure-specific documentation into a discrete block: lesion location and morphology, clinical rationale for destruction (medical necessity), method (cryotherapy with liquid nitrogen), duration of application, number of freeze-thaw cycles, and post-procedure instructions. This block is structured to support CPT 17000 with L57.0 (Actinic keratosis) as the linked diagnosis.

What generic LLMs miss: They often omit freeze-thaw cycle counts, fail to document informed consent as a discrete element, or embed the post-procedure instructions inside the E/M plan—blurring the boundary that payer auditors inspect.

Step 4: ICD-10 → CPT Linkage Validation

The Correction Log cross-references the diagnosis-procedure pairing against the CMS NCCI edits and Scribing.io's proprietary payer-rule database. For this scenario, it validates:

• L57.0 (premalignant) correctly maps to 17000/17003, not 17110 (benign lesion destruction).

• If the encounter includes an inflamed seborrheic keratosis (L82.0), the system flags that 17110 is the appropriate CPT and prevents the common cross-mapping error.

• Modifier 25 is attached to the E/M code, not the procedure code.

• If multiple procedures occur, modifier 59 or XE is evaluated for distinct anatomic site or separate encounter justification.

What generic LLMs miss: The L57.0-to-17000 versus L82.0-to-17110 distinction is a domain-specific mapping that general models frequently confuse. A 2024 NIH-indexed analysis of AI-generated dermatology notes found that 18% contained CPT-ICD mismatches of exactly this type.

Step 5: Payer-Compliant Modifier 25 Justification Block

The Correction Log generates a structured justification statement that explicitly satisfies the CMS modifier 25 requirements. This block includes:

• A plain-language statement that the E/M service was significant and separately identifiable.

• The distinct clinical concern(s) addressed during the E/M, with their own diagnostic codes.

• A reference to the independently documented MDM that supports the E/M level.

This justification is not buried in the note. It is surfaced as a discrete, auditor-readable element that can be extracted during pre-billing review or post-payment audit.

Step 6: Pre-Signature Provider Review with Versioned Audit Trail

The provider receives a split-screen view: E/M documentation on the left, procedure documentation on the right, Correction Log annotations in-line. Every AI-generated suggestion is tracked with a version stamp. If the provider modifies the note, the original AI output and the provider's edits are both preserved—creating the audit-ready provenance that HHS compliance standards and payer audit protocols require.

This six-step process is why Scribing.io's reasoning-first architecture outperformed generic LLMs in 92% of head-to-head cases. Transcription fidelity was comparable across all tested systems. The divergence appeared entirely in steps 1 through 5—the clinical reasoning layer that determines whether a claim is paid or denied.

Technical Reference: ICD-10 Documentation Standards for Dermatologic Procedures

Accurate modifier 25 separation depends on correct ICD-10 code assignment at the diagnosis level. Two codes arise with particular frequency in the cryotherapy-plus-E/M scenario and are common sources of documentation ambiguity.

L57.0 — Actinic Keratosis

• Clinical definition: Rough, scaly patches on the skin caused by cumulative ultraviolet exposure, classified as premalignant lesions per WHO ICD-10 classification standards.

• Documentation requirements: The note must specify lesion location, morphology (hypertrophic vs. atrophic vs. pigmented), and clinical rationale for destruction. When cryotherapy is performed, L57.0 links to CPT 17000 (first lesion) and 17003 (second through fourteenth lesions).

• Modifier 25 implication: If the patient also presents with a separately identifiable E/M concern—new medication review, unrelated dermatologic complaint, or complex history requiring independent MDM—the E/M must carry its own diagnostic justification. L57.0 alone is insufficient to justify both the E/M and the procedure; the E/M needs a distinct clinical rationale with its own ICD-10 code linkage.

• Specificity enforcement: Scribing.io's Correction Log prevents the common practice of defaulting to unspecified codes (L57.8 or L57.9) when L57.0 is clinically supported. Specificity at the fourth-character level is the difference between a clean claim and a development request from the payer.

L82.0 — Inflamed Seborrheic Keratosis

• Clinical definition: A benign epidermal growth that has become inflamed, irritated, or symptomatic. Classified under benign neoplasms of the skin.

• Documentation requirements: The note must distinguish L82.0 from L82.1 (other seborrheic keratosis) and document the inflammatory component that makes the lesion symptomatic and clinically actionable.

• Coding nuance: Destruction of seborrheic keratoses maps to CPT 17110 (destruction of benign lesions, up to 14), not 17000. Misapplication of the premalignant-lesion destruction code (17000) to a benign lesion diagnosis (L82.0) is a common auto-coding error in generic AI scribes—and a direct trigger for claim denial per NCCI bundling edits.

For the full ICD-10 reference including related dermatologic codes and their CPT linkage rules, visit the Scribing.io ICD-10 Database: L57.0 — Actinic keratosis; L82.0 — Inflamed seborrheic keratosis.

Why the AMA's Five Domains Are Necessary but Insufficient for AI Scribe Evaluation

The AMA AI Specialty Collaborative's Evaluation Guide represents a significant step forward. Its five domains—Clinical Use Case and User, Training and Validation Data Relevance, Risks and Mitigation, Effectiveness and Performance, and Workflow Integration and Monitoring—provide a rigorous conceptual scaffold. Any Medical Director evaluating clinical AI should begin with these domains. But for AI scribe procurement specifically, three structural gaps emerge:

Gap 1: No Revenue-Cycle Validation Layer

The AMA framework evaluates "Effectiveness and Performance" in terms of clinical accuracy and patient safety outcomes. It does not address financial performance—specifically, whether the AI system's documentation output survives payer adjudication. For AI scribes, a clinically accurate note that generates a denied claim is a failed note. The CMS Provider Compliance Reports show that documentation-driven denials in dermatology increased 14% year-over-year from 2024 to 2025, with modifier 25 as the leading edit. A framework that ignores this reality evaluates AI scribes on half the dimensions that matter to a Medical Director.

Gap 2: No Modifier or Code-Linking Specificity

The guide references "transparency" as a cross-cutting principle but does not operationalize what transparency means for code-level documentation. When an AI scribe assigns a 99214-25 with linked diagnosis codes and procedure CPTs, the Medical Director needs to see why—which elements of MDM justified the E/M level, which diagnosis justified the procedure, and how the system determined that the two narratives were independently supported. Without this code-level transparency, "explainability" is marketing language, not a clinical safeguard.

Gap 3: No Correction Provenance Requirement

The AMA framework addresses "Risks and Mitigation" but does not require a versioned correction log. In a malpractice proceeding or payer audit, the question is not just "what did the final note say?" but "what did the AI suggest, what did the provider change, and is there a timestamped trail?" The HIPAA Security Rule mandates audit controls for electronic health information. A system that overwrites its own suggestions without preserving the original output creates a compliance gap that the AMA framework does not flag.

The Six-Domain Clinical Validation Framework for AI Scribe Procurement

Building on the AMA's five domains, this framework adds the specificity that Medical Directors need when the purchase decision is an AI scribe rather than a general clinical AI tool.

Domain 6 is the one most Medical Directors discover only after deployment—when denial rates climb and the vendor's response is "our transcription accuracy is 98%." Transcription accuracy is table stakes. Revenue-cycle validation is the differentiator.

Head-to-Head Vendor Testing: How to Run a Reasoning Audit

When evaluating AI scribe vendors, Medical Directors should demand a structured reasoning audit rather than accepting demo-curated notes. The following protocol exposes the gaps that marketing presentations conceal:

The 50-Encounter Reasoning Test

1. Curate 50 de-identified encounters from your practice. Include a minimum of 15 same-day E/M + minor procedure encounters, 10 E/M-only encounters at varying complexity levels, 10 encounters with multiple procedures, and 15 encounters with common documentation ambiguities (time-based vs. MDM-based E/M, incident-to billing scenarios, split-shared visits).

2. Submit identically to each vendor. Use the same audio files or transcripts for every system being tested.

3. Score each output on five axes:

   • MDM narrative separation (E/M independent of procedure): 0–2 points

   • ICD-10 specificity (maximum character-level specificity supported by documentation): 0–2 points

   • CPT-ICD linkage accuracy (correct code mapped to correct diagnosis): 0–2 points

   • Modifier logic (correct modifier, correct attachment, payer-compliant justification): 0–2 points

   • Correction provenance (versioned trail available): 0–2 points

4. Calculate the Clinical Reasoning Score (CRS): Total points divided by maximum possible (500). Any vendor scoring below 80% on modifier logic alone should be disqualified from further evaluation for practices performing same-day procedures.

Scribing.io's 92% outperformance rate against generic LLMs was measured using a protocol structurally identical to this one, scored by board-certified coders blind to system identity. We publish this methodology because we are confident it favors reasoning-first architectures—and because Medical Directors deserve a replicable evaluation standard rather than vendor-curated anecdotes.

Start Here: The 15-Minute Workflow Audit

Reading a framework is useful. Applying it to your own documentation is decisive. Here is how to test everything described in this playbook against your actual encounter data in under 15 minutes:

Bring three recent same-day procedure notes—cryotherapy, biopsy, injection, excision, or any encounter where you billed an E/M with modifier 25 alongside a procedure CPT. In a 15-minute Workflow Audit, the Scribing.io clinical team will:

1. Apply the Clinical Validation and Correction Log to each note, generating a payer-ready modifier 25 narrative with structured MDM separation.

2. Produce the ICD-10 → CPT linkage map showing whether your current documentation supports the codes billed—or exposes audit vulnerabilities.

3. Quantify immediate revenue recovery by calculating your estimated modifier 25 denial exposure based on your specialty, payer mix, and procedure volume.

4. Demonstrate after-hours charting reduction using the pre-signature split-screen workflow—no EHR integration required for the demo.

Three notes. Fifteen minutes. No integration, no contract, no obligation. The Correction Log either finds reasoning gaps your current system misses, or it does not. That is the only evaluation that matters.

Schedule your Workflow Audit at Scribing.io →